Following recent recalls on lisinopril and ramipril, on December 6, the FDA announced the recall of an unspecified quantity of Nebivolol Tablets, manufactured by Aurobindo Pharma USA Inc., ...

Purpose. The pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of nebivolol are reviewed. Summary. Nebivolol, a third-generation, highly β 1-specific β-blocker, is labeled ...

Objective: To compare the haemodynamic effects of nebivolol, a highly selective antagonist of 1-adrenergic receptors with additional actions caused via the L-arginine/nitric oxide pathway ...